TELA BIO INC. - COMMON STOCK

TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference

21 дек 2022 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 дек 2022 16:02:00 Источник Nasdaq GlobeNewswire

TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference

21 ноя 2022 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio Reports Third Quarter 2022 Financial Results

09 ноя 2022 16:01:00 Источник Nasdaq GlobeNewswire

TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum

03 ноя 2022 07:00:02 Источник Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 окт 2022 16:05:00 Источник Nasdaq GlobeNewswire

TELA Bio to Announce Third Quarter 2022 Financial Results

27 окт 2022 07:00:01 Источник Nasdaq GlobeNewswire

TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repair

26 окт 2022 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Investor Conferences

01 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire

TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase

23 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

18 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

TELA Bio Announces Pricing of Public Offering of Common Stock

15 авг 2022 22:20:00 Источник Nasdaq GlobeNewswire

TELA Bio Announces Proposed Public Offering of Common Stock

15 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

TELA Bio Reports Second Quarter 2022 Financial Results

10 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Investor Conferences

05 авг 2022 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repairs; Data to Be Presented at 2022 American Hernia Society (AHS) Meeting

04 авг 2022 07:00:02 Источник Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29 июл 2022 16:01:00 Источник Nasdaq GlobeNewswire

TELA Bio to Announce Second Quarter 2022 Financial Results

27 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc.

20 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference

02 июн 2022 07:00:00 Источник Nasdaq GlobeNewswire